This is the latest news as of February 6th.

"Scientists for the Food and Drug Administration say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects."

I'll post more if I find anything else out.